Vanderbilt University Licenses Ariadne Pathway Studio
News Jul 12, 2007
Ariadne has announced that Vanderbilt University purchased an unlimited Pathway Studio license for the Department of Cancer Biology. Pathway Studio was chosen for its flexibility in exploring protein-protein interactions and ease of frequent database updates with MedScan® module.
“We evaluated various pathway analysis packages and were impressed by Pathway Studio’s graphics and ease of use.” said Dr. Lynn Matrisian, Chair of the Department of Cancer Biology at Vanderbilt University.
“Most impressive is the MedScan Technology that allows our researchers to extract relationships from the latest publications and add them to the large body of knowledge in the packaged database. The ability to instantly update the database with selected information is of paramount importance in cancer research," Dr. Matrisian continued.
‘We start seeing more and more research groups choosing Pathway Studio over other pathway software based on the availability of MedScan and therefore the researcher’s ability to fully control the database and update it as often as needed”, said Ilya Mazo, President of Ariadne.
“Ease of making custom databases together with the biggest available database of functional relationships and flexibility of pathway analysis queries proves to be the most important advantages of our software among researchers in academia and pharmaceutical companies.”
More and more consumers are using services like 23andMe to learn about their genetic blueprint. Included with most of these services is the ability for users to download their "raw" genetic data, which can be further analyzed using third-party apps. But little is known about how and why consumers are using these apps, or about a variety of potential risks associated with these apps, until now.READ MORE